(Q39944336)

15 September 2017

1 reference

title

Cell-Mediated Immunity to Tumor Cells (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4604193

11 February 2023

author name string

R. B. Herberman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4604193

11 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4604193

11 February 2023

publication date

1 January 1974

1 reference

Advances in Cancer Research

15 September 2017

published in

1 reference

15 September 2017

volume

19

1 reference

15 September 2017

issue

0

1 reference

15 September 2017

page(s)

207-263

1 reference

Studies on delayed hypersensitivity in Hodgkin's disease

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Potentiation of viral carcinogenesis by immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effects of antilymphocyte serum on virus oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effect of autologous mammary tumour extracts on human leukocyte migrationin vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Leukemia-associated antigens in the mixed leukocyte culture test

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Embryonic antigen expression in chemically induced rat hepatomas and sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Requiem for the Nature Conservancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Increased Oncogenic Effect of Methylcholanthrene after Treatment with Anti-lymphocyte Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Antigenic diversity of tumors chemically induced within the progeny of a single cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

IMMUNOLOGICAL HOMOGRAFT ENHANCEMENT. INTERACTIONS OF ANTISERUM AND SKIN AND TUMOR HOMOGRAFTS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Quantitative Studies on Tissue Transplantation Immunity. II. The Origin, Strength and Duration of Actively and Adoptively Acquired Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular responses to autologous breast cancer tissue:Correlation with stage and lymphoreticuloendothelial reactive

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

A specific complement-fixing antigen present in SV 40 tumor and transformed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro approaches to the mechanism of cell-mediated immune reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Influence of neonatal thymectomy upon the cell-mediated tumor-specific immunity in Rous sarcoma virus tumorigenesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro desensitization of sensitized murine lymphocytes by a serum factor (soluble antigen?).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Enhancing effect on tumour growth of humoral antibodies against tumour specific transplantation antigens in tumours induced by murine sarcoma virus(Harvey).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular and humoral immune responses to human urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular immunity to renal carcinomas in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cancer; a biological approach. I. The processes of control

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Presence of carcinoembryonic antigen in children's colonic mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Tuberculin-Active Carbohydrate That Induces Inhibition of Macrophage Migration but not Lymphocyte Transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration of Carcinoembryonic Antigen in Normal Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

1 reference

7 January 2021

Postoperative Depression of Tumour-directed Cell-mediated Immunity in Patients with Malignant Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Host immunity to growing sarcomas: tumor-specific serum inhibition of tumor-specific cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Transformation of human lymphocytes: inhibition by homologous alpha globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cytotoxic lymphocytes in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immunosurveillance and cancer: epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Further studies of the stimulation of DNA synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Impaired immunologic reactivity and recurrence following cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular and humoral immunity against human malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular immunity to human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Occurrence of malignancy in immunodeficiency diseases. A literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Specific carcinoembryonic antigens of the human digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular reactions against Burkitt lymphoma cells. II. Effector cells obtained by allogeneic stimulation in mixed leukocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular reactions against Burkitt lymphoma cells. 3. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

HOMOGRAFT TARGET CELLS: SPECIFIC DESTRUCTION IN VITRO BY CONTACT INTERACTION WITH IMMUNE MACROPHAGES.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effect of Neonatal Thymectomy on the Induction of Papillomata and Carcinomata by 3,4-Benzopyrene in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immunoglobulin on Tumor Cells and Tumor-Induced Lymphocyte Blastogenesis in Human Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Resistance of polyoma virus immune animals to transplanted polyoma tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Macrophage migration inhibition with mouse tumor antigens: Properties of serum and peritoneal cells during tumor growth and after tumor loss

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

International Whaling Omission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cellsin vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Studies on cellular immunity and its serum-mediated inhibition in moloney-virus-induced mouse sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to moloney sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro demonstration of humoral and cell-bound immunity against common specific transplantation atigen(s) of adenovirus 12-induced mouse and hamster tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration of cell-bound and humoral immunity against neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular immunity and its serum-mediated inhibition in shope-virus-induced rabbit papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Studies on cellular immunity to human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration of cell-mediated immunity to human neoplasms of various histological types

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Destruction of cultivated melanoma cells by lymphocytes from healthy black (North American Negro) donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular Immunity Against Tumor Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immunological Enhancement as Studied by Cell Culture Techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Specific cytolytic activity of lymphocytes: effect of antibodies against complement components C2, C3, and C5

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Studies on serum-mediated inhibition of cellular immunity to spontaneous mouse mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro studies on cell-mediated immunity following surgery in mice sensitized to syngeneic mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

A dilute agar colony inhibition (CI) test for studying cell-mediated immune responses against tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro demonstration of tumor-specific antigens in spontaneous mammary tumors of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immune and natural antibodies to syngeneic murine plasma cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Impaired in Vitro Lymphocyte Transformation in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular reactions against Burkitt Lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Control of Carcinogenesis: A Possible Role for the Activated Macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

IMMUNE RESPONSE AND MITOSIS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Separation of Skin Reactive Intestinal Cancer Antigen from the Carcinoembryonic Antigen of Gold

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Delayed-type hypersensitivity in mice after skin and tumour allografts and tumour isografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

STUDIES ON CYTOPHILIC ANTIBODIES

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

TUMOR VIRUS STUDY SYSTEMS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

ANTIGENIC PROPERTIES OF HUMAN TUMOURS: DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Suppression of the tuberculin response in malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated and humoral immune responses to tumor-associated and viral antigens in relation to the pathogenic effect of Rous sarcoma virus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Role of immunologic disturbance in human oncogenesis: some facts and fancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The regulatory influence of activated T cells on B cell responses to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immunosurveillance and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

1 reference

7 January 2021

Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Tumor-specific antigens detected by inhibition of macrophage migration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cancer caused by an inherited selective defect in immunological surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

NEOPLASMS IN THYMECTOMIZED MICE FOLLOWING ROOM INFECTION WITH POLYOMA VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Influence of total body x-irradiation on tumor induction by parotid tumor agent in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Professor J. D. Bernal

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Demonstration of antigens related to colonic cancer in the human digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated “Immunostimulation” induced by Mammary Tumour Virus-free Balb/c Mammary Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Influence of Antilymphocyte Serum on DMBA Induction of Oral Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Passive transfer of transplantation immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effect on Tumour Growth in Syngeneic Recipients of Antibodies Against Tumour-Specific Antigens in Methylcholanthrene-Induced Mouse Sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immunological reactivity in patients with carcinoma of colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

IMMUNOLOGY OF EXPERIMENTAL TUMORS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Specific inhibition of tumor cell DNA synthesis in vitro by lymphocytes from peritoneal exudate of immunized syngeneic guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro activation of cellular immune response to Gross virus-induced lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Specificity of cellular immune reactivity to virus-induced tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cellular immunity to human urinary bladder carcinoma. II. EEffect of surgery and preoperative irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cytotoxic effects of lymphoid cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Specific killing of tumor cellsIn vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Recognition of leukaemia cells as foreign before and after autoimmunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The immune reaction as a stimulator of tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

A more sensitive test for alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Mixed leukocyte reactivity and leukemia: study of identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

α-Foetoprotein in Normal Human Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effect of autologous tumor extracts on cultured human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Hodgkin's disease and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Failure to demonstrate immunity to leukemia associated antigens by lymphocyte transformation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro study of cellular immunity against autochthonous human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The functional dissection of an antigen molecule: specificity of humoral and cellular immune responses to glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Tumor-Specific Immune Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors.3. The frequency, duration, and cross reactivity of this phenomenon in patients with breast cancer, and its correlation with survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

ANTIGENIC CONVERSION OF ESTABLISHED LEUKEMIAS BY AN UNRELATED LEUKAEMOGENIC VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

A microassay for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immunological studies on urinary bladder tumors of rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell Migration Inhibition Factor released by Antigen from Human Peripheral Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Expression of fetal antigens in tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Antibody-Dependent Lymphoid Cell-Mediated Cytotoxicity: No Requirement for Thymus-Derived Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Cell-mediated Immunity in vitro against Syngeneic Mouse Plasma Tumour Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

A quantitative investigation of the G (Gross) antigen in preleukemic and leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Delayed hypersensitivity to extracts from primary sarcomata in the autochthonous host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

In vitro Assay of Cell Mediated Immunity in Human Cancer: Definition of Leukocyte Migration Inhibitory Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Immune Response to Gross Virus-Induced Lymphoma: Comparison of Two In Vitro Assays of Cell-Mediated Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960055-X

7 January 2021

1

31

864

Adler

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

11

31

997

Ankerst

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

12

26

1415

Aoki

1966

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

13

26

1787

Attia

1966

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

29

28

1410

Batchelor

1968

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

The Concept of Immunological Surveillance

11 February 2023

series ordinal

60

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

78

31

882

Datta

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

Cytotoxicity of murine peritoneal macrophages in tumour allograft immunity.

11 February 2023

series ordinal

84

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

89

9

217

Dulaney

1949

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

97

27

2207

Fefer

1967

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

101

13

835

Foley

1953

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

125

3

326

Gross

1943

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

132

33

2886

Harada

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

137

28

1839

Haughton

1968

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

198

18

992

Kaliss

1958

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

207

19

343

Klein

1959

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

211

20

452

Klein

1960

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

212

20

1561

Klein

1960

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

225

26

551

Law

1966

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

226

29

1

Law

1969

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

233

32

1820

Leventhal

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

237

32

477

Levy

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

253

28

1441

Miller

1968

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

255

32

825

Mitchell

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

263

37

2845

Oettgen

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

266

25

813

Old

1965

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

294

27

1243

Reiner

1967

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

Texas Reports on Biology and Medicine

11 February 2023

313

29

227

Sinkovics

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

317

31

890

Sjögren

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

318

21

329

Sjögren

1961

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

322

22

947

Slettenmark

1962

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

328

28

1433

Southam

1968

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

346

33

2898

Takasugi

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

353

28

2477

Vaage

1968

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

354

32

680

Vaage

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

366

16

831

Witebsky

1956

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60055-X

11 February 2023

Identifiers

0 references

1 reference